Watch now: Psychedelics and Grief: When Containment Stops Working 

Psychedelics and Grief
Watch now: Psychedelics and Grief: When Containment Stops Working 

Supporting women in the wild with science and wisdom about psychedelics.


S2 Salon Grief.mp4

134. Psychedelics and Grief: When Containment Stops Working

Dr. Sunil Aggarwal joins April Pride to talk psilocybin, grief, and the difference between containing a loss and integrating it. April Pride Sep 29

Recently, it occurred to me that my relationship with trust needed tending. When I told a friend, she asked, “Why don’t you trust yourself?” I’ve been sitting with that question because it tracks and it confuses me at the same time. I’ve walked into divorce, entrepreneurship, and work in the Schedule I-adjacent world. Not the choices of someone with zero self-trust.

Here’s where I’ve landed. Trust and grief are more entangled than I’d realized. Grief is what’s left when something we relied on breaks: a person, a marriage, a plan, a version of ourselves. Trust is what we have to rebuild afterward, in others and in our own judgment. Losing one tends to shake the other.

Today’s episode is the live recording of last season’s final Psychedelic Salon covering psychedelics to address grief. Among other related topics, Dr. Sunil Aggarwal joined me to talk about the integration versus containment of grief, and it reframed how I think about loss as a trust event as much as an emotional one.

In recent months, these weekly dispatches have mostly been a home for live recordings from last season’s Psychedelic Salon, and that will continue as new Salons roll out when the season begins at Town Hall Seattle next week. For the final quarter of 2026, though, I’m excited to begin a 12-week microdosing protocol that I’ll document here on Substack, similar to my Microdosing for Midlife series, which was published weekly in the summer of 2025.

I invite you to follow along as I explore my own relationship with trust while making sense of the science behind how trust is formed, lost, repaired, and gained.

At its best, trust is implied. Without it, connection gets sabotaged, communication turns sus, and the vibe goes sketch. In a world of misplaced trust and louder, more opposed voices, I don’t think I’m the only one whose relationship with trust needs tending.

Enjoy today’s episode, and join me for this series to close out 2026. Trust me.

Take care,

April

P.S. You can watch this episode on YouTube here or Spotify here, and while you’re there, subscribe to the show!

APRIL PRIDE is a reader-supported publication. To support my work, consider becoming a free or paid subscriber.

Upgrade to paid


🔵 Episode Summary

This episode is about psychedelics and grief, and it starts from an unusual place: not death, but everything else grief actually is. Loss of a future you thought you had. Loss of an identity, a marriage, a body that no longer works the way it used to. That’s the frame Dr. Sunil Aggarwal and I set for this final Psychedelic Salon of last season, recorded live at Town Hall Seattle.

Sunil isn’t a hospice tourist to this topic. He’s a physician at Seattle’s AIMS Institute who has spent years fighting, in federal court, for his own terminally ill patients’ right to try psilocybin. He was the first doctor to petition the DEA for Right to Try access on their behalf, working alongside right-to-die attorney Kathryn Tucker, and a Ninth Circuit panel eventually told the DEA it had erred in denying that petition. That fight is the backdrop for everything else we talk about: the neurobiology of why a guided psychedelic experience can shift a story you’ve carried about a loss for years, a bereaved-parent retreat in Jamaica that’s now the subject of a real qualitative study, and the distinction Sunil keeps returning to, containment versus integration.

Containment is what most of us default to. Put the loss in a box, keep functioning, call it managed. Integration is slower, and it’s the only version of the two that actually changes your relationship to what you lost. Not less pain. A different relationship to the pain.

We also get into what the research does and doesn’t support, from the fast-tracked synthetic psilocybin analogs now moving through the FDA (which change access for almost no one, since more than 99.9% of psilocybin used in the US still comes from mushrooms) to the early, mostly preclinical evidence on psilocybin and brain injury. And we close on the one resource almost nobody uses: every hospice in the country is legally required to offer 12 months of bereavement support, to anyone in the family, whether or not you were ever a patient there.

Upgrade to paid


Watch now: Psychedelics and Grief: When Containment Stops Working 

October 8 – The History of LSD in Seattle: From Outlaw to FDA-Approved

Nov 12 – End-of-Life Psychedelic Care

February 11 – Moving Through Middle Age with Psychedelics

March 11 – Psychedelics in Recovery

April 8 – Modern Men: Psychedelics, Vulnerability, and the Masculine Self

May 13 – Making Meaning: Story, Integration, and the Psychedelic Experience

Learn more

All Psychedelics Salons are live at Town Hall Seattle and available for livestream. 2nd Thursdays @ 7:30pmPT


🔵 What You’ll Learn in This Episode

  • Grief is loss broadly defined: not only death, but the loss of a future, an identity, a capacity, a body, a marriage. Sunil frames “anticipatory grief” as something people can experience years before an actual death.
  • Containment versus integration is the operating distinction of this episode. Containment manages a loss out of daily awareness. Integration, which Sunil says is measured in years, not sessions, changes how you carry it.
  • A 2022 report in the Journal of Pain and Symptom Management documented four group psilocybin retreats in Jamaica for 21 parents who’d lost children unexpectedly. This is field reporting and case documentation, not a randomized controlled trial, and it’s only possible because Jamaica doesn’t schedule psilocybin the way the US does.
  • Psilocybin’s effect on the brain’s default mode network, the “autopilot” behind rumination and self-narrative, is one proposed mechanism for why a single guided experience can loosen a grief story that’s calcified over years. This mechanism is established neuroscience; how directly it explains any one person’s outcome is not.
  • Psychedelics and brain injury is a genuinely active research area, but the human evidence is still early: a single coma case study, and one small observational veterans study without a control group. The animal data (less tissue damage after psilocybin in mouse stroke models) is real and published.
  • Every hospice in the US is required by law to provide 12 months of bereavement support to any family member, whether or not their loved one was ever formally enrolled as a patient. It’s free, and it’s underused.

🔵 Featured Guest

  • Dr. Sunil Aggarwal is a physician at Seattle’s AIMS Institute, where he leads an integrative oncology and palliative care practice and directs the clinic’s psychedelic-assisted work with ketamine and psilocybin. He holds an MD and PhD from the University of Washington School of Medicine, where his doctoral work was in medical geography. Aggarwal was the first physician to petition the DEA for Right to Try access to psilocybin for terminally ill patients, litigation that produced a Ninth Circuit ruling finding the DEA had erred in denying that petition, a first for the agency. His clinical and legal work sits at the center of the current fight over who gets access to psychedelic medicine, and under what conditions, before federal rescheduling catches up.@sunil1007 @aimsinstituteseattle

🔵 Episode FAQs

Is psilocybin legal for end-of-life or grief care in the US? No. Psilocybin remains a federal Schedule I substance. Oregon’s Measure 109 and Colorado’s Natural Medicine Health Act (Proposition 122, passed 2022) created state-level licensed access programs, but neither changes federal law, and neither is grief- or hospice-specific.

What is Right to Try, and does it apply to psilocybin? The federal Right to Try Act lets patients with a life-threatening condition access certain investigational drugs outside a clinical trial. Dr. Aggarwal and attorney Kathryn Tucker argued it should apply to psilocybin for dying patients; the DEA disagreed, and a Ninth Circuit panel found the agency had erred in that denial. The underlying legal question about psilocybin access is still unresolved.

What’s the difference between the psilocybin moving through FDA fast-track review and the psilocybin most people use? The FDA review covers synthetic psilocybin analogs from two pharmaceutical companies. Well over 99% of the psilocybin actually used in the US comes from mushrooms, a separate manufacturing and legal pathway that fast-tracked pharmaceutical approval doesn’t touch.

What are the Kübler-Ross stages of grief, and do they still hold up? Elisabeth Kübler-Ross developed denial, anger, bargaining, depression, and acceptance in 1969 by studying dying patients, not grieving survivors; they were later applied to grief more broadly. Grief researcher David Kessler, who studied under her, later added a sixth stage, meaning, and most current grief research describes the process as nonlinear rather than a checklist completed in order.

Does every hospice really have to offer free bereavement support? Yes. US hospices are required to provide bereavement support for 12 months following a death, open to any family member regardless of whether they were formally enrolled as a patient there. You can call any local hospice agency and ask, even with no prior connection to it.


🔵 Additional Resources

  • Psychedelic Salon at Town Hall Seattle – 2026-27 Schedule
  • Companion Q&A post: “Q: Can psychedelics help with grief?” — the full audience Q&A from this same Salon, live the following Tuesday. [Link once live.]
  • Jamaica Grief Retreats, led by Dr. Dingle Spence, the group retreat program for bereaved parents discussed in this episode. Findings published as “Relief for Grief: Report from a Psychedelic Retreat for Bereaved Parents in Jamaica,” Journal of Pain and Symptom Management, 2022.
  • The Wild Edge of Sorrow: Rituals of Renewal and the Sacred Work of Grief, Francis Weller. Referenced in the Q&A companion episode; useful context for anyone who wants the “five gates of grief” framework beyond death.
  • AIMS Institute, Dr. Aggarwal’s Seattle clinic. [Link once supplied.]
  • To find hospice bereavement support in your area, call any local hospice agency directly and ask for their bereavement program. You do not need a prior relationship with that hospice to use it.
  • Monthly microdose gatherings for women in Seattle. Apply here.

🔵 Timestamps

0:00 Welcome, disclaimer, and the topic of this Salon: grief 0:45 Meet Dr. Sunil Aggarwal: hospice, palliative medicine, and medical geography 2:20 The Right to Try fight to get psilocybin to dying patients 5:00 Who controls psilocybin’s Schedule I status, and why the FDA’s fast-tracked analogs won’t change access for most people 6:30 April’s own experience with grief, and the parents who come to her after losing a child 8:30 How Sunil recognizes grief in a clinical setting, and what anticipatory grief looks like 11:30 Containment versus integration 12:20 Inside the Jamaica grief retreats for bereaved parents 17:20 The neurobiology of psilocybin, the default mode network, and reframing a loss 19:10 How to integrate a psychedelic experience afterward 22:20 The bereavement benefit almost no one uses 23:40 Key takeaways and what’s ahead this season


🔵 Transcript

Show Disclaimer

[00:00:00]

April Pride, host: Hey, this is April, and this show discusses psychedelics. It’s intended for audiences 21 and over. Also, I am not a medical expert. If you are looking to engage with psychedelic substances, please consult your physician before doing so.

Salon Theme Grief

April Pride, host: Welcome back to the show. This is your host, April Pride. This episode features the final Psychedelic Salon from last season at Town Hall Seattle, recorded live and built around one topic, the topic that I’ve found is drawing people to psychedelics most frequently, and that is grief.

Not only the grief of death, the grief of a future you thought you had, an identity, a marriage, a body that doesn’t work the way it used to. Dr. Sunil Aggarwal, has background in psychedelics as a doctor fighting on behalf of his [00:01:00] patients for the right to try psilocybin at end of life. He’s about to introduce himself. I’m gonna let him because his background is extensive.

And one thing before we start, psilocybin still is Schedule 1 federally and nothing in this conversation is medical advice. Enjoy today’s episode

Meet Dr Aggarwal

Dr. Sunil Aggarwal : Hello, my name is Sunil Aggarwal. I’m a graduate of the University of Washington School of Medicine.

I did the medical scientist training program there. So it took me additional four and a half years to do some, graduate work, and I did that in the field of medical geography, which is a discipline that’s like looking at the human environment relationship and how it applies to health and disease, both, distribution of diseases an overlap with public health, but also taking an ecological focus and looking at, how does the environment play a role or even political and social factors, and also access to care, systems of care, health systems.

After I finished my PhD in MD here, I decided to specialize in hospice and palliative [00:02:00] medicine. through physical medicine and rehabilitation, that’s what I ended up focusing my clinical work in because in these areas, this is a chronic illness, serious illness, life-threatening illness.

There’s a lot of opening and interest in all integrative medicine, systems of healing that aren’t just the straight conventional path. A lot of times people don’t have good healing options, and are open to new ideas these substances

Right to Try Fight

April Pride, host: Dr. Aggarwal was the first, to petition the DEA for Right to Try for his patients, to be able to use psilocybin, for end of life,

Dr. Sunil Aggarwal : back in 2000, I worked with a wonderful attorney named Catherine Tucker,

she’s argued cases before the Supreme Court, on, the rights for terminally ill patients to have, the right to die, a right to withhold treatments, and medical aid in dying, things like that.

she’s really, passionate about making life meaningful even if your life span is limited and you know it. But you’re still alive, and you still have autonomy. You have choices. And, she realized that, because of the [00:03:00] studies that were done at NYU, and other places that, psilocybin had a huge role to play in helping people, deal with that, challenging time when they get a terminal diagnosis

we teamed up through this, organization called End of Life Washington She asked me if I had patients who might wanna try psilocybin who are dealing with that. And in my clinic, AIMS Institute, we have integrative oncology track, and so I had a number of patients that were interested

But most people didn’t know what to do. She said we just ask them,” there was really no pathway and, but it made sense to her. And it turned out it became a big legal argument between the, DEA’s definition of the Schedule 1, doesn’t apply to Right to Try, even though the Right to Try law, which is a, Food Drug Cosmetic Act law, says any drug that’s past Phase 1 clinical trials, if it’s safe, it’s eligible to be used, as long as you have informed consent, and as long as you have a manufacturer willing to provide it to you.

And we had all of those things, but we just didn’t have a pathway to do it. And so [00:04:00] we argued that, and we had two or three Ninth Circuit case hearings, and, ultimately, we ended up having to, file a petition to reschedule psilocybin from Schedule 1 to Schedule 2, is what we asked for, based on so much data.

Johns Hopkins researchers had written a paper specifically on this. Matthew Johnson and, the late Roland Griffiths. One of the pioneering researchers in this field, had stage four, colon cancer, he interviewed with the New York Times, he said that he also used psychedelics at the end of his life there, and how profoundly healing it was for him.

The courts told the DEA that they had erred in denying our rescheduling petition, so that was the first time The DEA ever was told by a court, you did wrong here to allow a drug to stay prohibited and in your highest category of control.

Policy and Pharma Divide

Dr. Sunil Aggarwal : Why is it people with guns versus people with lab coats that decide, drug policy? Robert F. Kennedy Jr.’s HHS is sitting on this or holding it since August. And so we’re really hopeful now with this executive order, which is basically fast-tracking a couple of, [00:05:00] psilocybin, drug applications through the FDA,

April Pride, host: Synthetic psilocybin analog-

Dr. Sunil Aggarwal : analogs y- yes.

April Pride, host: and- So the rub there is that they could get rescheduled, but not natural mushrooms.

Dr. Sunil Aggarwal : Yeah, and this is where, people need to know what’s happening here. 99.9% of all the psilocybin, in the USA, and probably the world is produced in mushrooms.

Less than .1% of psilocybin that’s produced by these pharmaceutical companies, Usona and Compass. That’s the psilocybin that they’re talking about, moving forward. But anybody with a, high school chemistry knows, okay that’s the same compound that’s in here.

And, so then you know clearly that there’s an incentive of economic development and not public health that’s driving that. But the schedules are laws for everybody, not just for the companies. So I’m hoping that, we may not have to take them to court again.

April Pride, host: Two quick corrections and a piece of context here. The attorney Sunil’s describing is Kathryn Tucker,

one of the country’s most prominent right [00:06:00] to die attorneys. She argued Washington v. Glucksberg in front of the Supreme Court in the ‘90s, and Dr. Aggarwal’s clinic, the AIMS Institute, and now sit with the number he just gave you. Over 99.9% of the psilocybin used in this country still comes from mushrooms, not the synthetic version two pharmaceutical companies are racing to get through the FDA.

Whatever comes out of the fast-tracked review changes access for almost no one, since it’s a different manufacturing pathway than what nearly everyone growing or using psilocybin actually relies on. That’s the system Sunil is working inside of as a physician trying to get his own dying patients legal access

Dr. Aggarwal does focus on palliative care and end of life.

Host Grief Stories

April Pride, host: But for me, my experience with grief and psychedelics had everything to do with a divorce, and I didn’t know I was experiencing grief. I thought I was having [00:07:00] situational depression. It’s important that we recognize that grief is loss.

It’s not just loss of life, it’s loss of a future, it’s loss of an identity, loss of fertility, loss of our society. So we are all collectively experiencing grief, whether it’s as individuals, and we have to recognize that, we’re all in this place of what the fuck is going on- and what can we do about it?

When it comes to grief psychedelics help people access their emotions, help people have self-compassion, help people to,

Tell themselves a different story, right? So that they can see grief from outside of everything that they’ve attached to it. It’s meaning-making. This making meaning keeps coming up. When people are grieving, they’re just [00:08:00] trying to make sense of what they’re now supposed to do the second time that grief and psychedelics intersected for me is I have a lot of parents who have lost children to overdose, who come to me because they feel a lot of shame talking to even people in their life, and they’ve turned to psychedelics to help them figure out how to go on, how to stay married, how to continue to be a parent for their other children.

Recognizing Grief Clinically

April Pride, host: In your practice, when you’re working with a patient- how do you know they’re grieving? Are there symptoms? Are they talking about it?

Dr. Sunil Aggarwal : There’s something called anticipatory grief. This is the first thing that I… When they started teaching us to pay attention to grief and ways that people don’t have words for. And this is, ‘cause I do work with a lot of palliative care patients, and their families. There is this experience that, might happen, years and years before their loved one dies that they’re already anticipating what that’s gonna [00:09:00] look like and feel like, and they go through these experiences and, you might know Elisabeth Kübler-Ross’ stages of grief.

denial, anger, bargaining, acceptance and, there’s these different flavors of those kinds of experiences of emotions. And sometimes it’s all of them at once or a couple of them or you cycle through them. But it’s looking at listening for loss, an awareness that something might be not there.

Is gone or might be going away and some of these other emotions around it. I think that’s how we, start to notice it and it is a lot more widespread. if you think about, The climate, or, ecological things.

People previously, run a marathon or climb up someplace, but their body doesn’t allow them to do that anymore. they grieve certain losses of capacity. So you see it in disability, you see it in aging, you see it in death, and you see it collectively.

and so it’s a natural part of life too. It’s not like this is a terrible thing. I just think We are so ill-equipped [00:10:00] oftentimes with the tools and capacities to hold grief, to be with it, to recognize it, and to do the work that’s spiritual to, ‘cause grief can be a wonderful opportunity for things to change and for life to move in a certain way.

And then, recognize our own mortality and, that we will all die. And how do we use these opportunities of loss to help us think about the people that will grieve us when we go I wanna normalize it too.

it’s not something that we wanna run away from.

April Pride, host: Sunil just named the Kübler-Ross stages, denial, anger, bargaining, depression, acceptance, and it’s worth knowing where that model actually came from and where grief research has moved since. Elisabeth Kübler-Ross developed those stages in 1969, and she developed them by studying dying patients, not grieving survivors.

They got applied to grief almost by accident, and the decades of research since have found that most people don’t move through them in order or at all in a tidy line. Grief researcher David [00:11:00] Kessler, who studied under Kübler-Ross, eventually added a sixth stage, meaning, not resolution

Meaning that’s closer to what Sunil is describing, grief as something you build in relationship with, not a checklist you complete. Keep that in mind as he talks about integration next

Containment vs Integration

April Pride, host: there’s containment, right? That’s how we deal with grief. We just put it in the back of our mind, this bad thing happened.

I should be affected by it. I’m sure that I am. But it doesn’t get integrated into your future, right? You’re not living with it. You are just managing it out of your existence for survival, right? And so this idea of containment versus integration, containment versus surrender, and that’s the work that you’re talking about, right?

, When we talk about psychedelic integration, it is years of work. And it takes time to be at peace with what [00:12:00] is. And anyone in this room that has had psychedelics understands how it can help you process grief But processing it doesn’t mean there’s an end goal. It’s, again, trying to help you figure out how you integrate it into your life.

Jamaica Grief Retreats

Dr. Sunil Aggarwal : So in the field of palliative care, we had, two, doctors present a couple of years ago about their experience of leading, grief healing retreats in Jamaica for, a lot of American patients This one doctor was in LA, a pediatric palliative care physician, and he, teamed up with, a doctor in Jamaica named Dingle Spence.

In Jamaica, psilocybin mushrooms are not criminally regulated. they have different type of regulations. So they hosted, I have some numbers here for you. they did bereavement support groups, with two groups of parents who’d lost children. So this is a very difficult area of grief.

they had hosted, at the time this [00:13:00] article was written, four retreats for parents of 21 children who had died suddenly, unexpectedly. many parents found the experience therapeutic for processing complicated emotions. And this is a quote from, the doctor when she was being interviewed by one of our, journals.

“Can you express joy? Are you allowed to be happy again, ever? Because the minute that you’re happy again, does that mean you’re betraying your child?” she explained, think that, what we’re able to do is provide a safe enough of a container to have that process of integrating that joy with, and reconciling these feelings of guilt, of basically that survivor’s guilt.

That’s that sense that I live on, but the person that I loved is no longer here.” And, that’s a tough one. But I wanted to bring it up ‘cause it’s … these are hard and it’s wonderful to have something like psilocybin that can help you tap into things in a different [00:14:00] way, a different perspective.

And not just temporarily, but then how to make that stick, the plasticity of it and the integration of it. And then of course, being around other people that have dealt with similar losses. This is not something you wanna isolate and deal with in your aloneness. I think it’s really important to have that dimension.

So it was a … These were group retreats, not individual. So I wanted to share that with you.

April Pride, host: Yeah. That study is re- is interesting. and it made me think of, the opposite of love is indifference. And when you continue to have strong, not very kind emotions about someone, it keeps you attached to them, right?

Same with grief. When you’re in active grief, you are still connected to what or whom you’ve lost. And what psychedelics can help you do is to have a more positive connection in the future with that loss. You can still be connected to them, but it’s not at your own expense.

Dr. Sunil Aggarwal : There was a whole debate about when does grief turn to be pathological, then [00:15:00] we started using this term complicated grief, and so it’s the grief that sort of goes on and does lead to, more loss of role fulfillment, other, health challenges, neglect, internal neglect.

That’s where things can go awry. Dr. Spence in this article, she said that she had her own psilocybin experience and that it happened a month or two after her mother passed.

She was amazed to see how it did help her process that, So it doesn’t necessarily have to be in this complicated stage of grief reaching for this or that’s part of your healing. But, it could help the normal grieving process

And I think, we don’t have those kind of ritual containers to help people reintegrate to honor the loss and memory in a certain way. We have funerals, we have those rituals, but sometimes we need something more and deeper. And I think that’s what traditional cultures, many of them have integrated psychedelics into their systems to help people with major transition points in life.

April Pride, host: the retreat Sunil is [00:16:00] describing is called Jamaica Grief Retreats, led by Dr. Dingle Spence, and the numbers he cited for retreats, 21 bereaved parents, come from a report published in the Journal of Pain and Symptom Management in 2022. Jamaica doesn’t schedule psilocybin the way the US does, which is the only reason a group retreat like this can legally exist right now for grieving American parents.

There isn’t a randomized control trial behind this yet. This is field reporting and case documentation, not a clinical trial with a control arm

What it does establish is that group psilocybin work with bereaved parents is happening, it’s being written up, and parents in it are describing something specific, not less pain, but more capacity to hold it

Dr. Sunil Aggarwal : That’s how I see grieving as part of that. when you lose your parents, for example, or, some other, major generational loss, that’s where we can, find some help with these, allies. And it’s important to [00:17:00] recognize the integration is, where everything is at ‘cause you can have, a powerful, let’s say that favorite movie you saw someday, and it was really, you were really exhilarated, and then, you don’t feel exhilarated right now, as much because you don’t remember what movie I’m talking about But just think about how there’s certain joyful experiences that you have that don’t really stay with you, that don’t really get into your bones

But we’re talking about things that could potentially fundamentally, alter your reactivity and change the way that you wire and fire your neurons when you have certain stimulus like a loss.

Brain Science of Psilocybin

April Pride, host: Can you explain exactly what that neurobiology is?

How it can help to reframe grief.

Dr. Sunil Aggarwal : We’re dealing with the most complex piece of, matter in the universe possibly, this human brain, so many, neuronal connections, more than, stars in the universe. but we do know These substances are neurotransmitter analogs, that they look like the same chemicals that our neurons are using to, communicate with each other. It seems [00:18:00] like, when people are under the influence of psilocybin, the brain’s default mode network, which is a certain series of regions that are all talking to each other, whenever you’re daydreaming or just not doing anything in particular, that system is suppressed or interrupted.

and now you have different channels of connectivity and communication in regions that aren’t normally talking to each other. A much higher entropy brain during the phase of the psilocybin activity.

This is a signature of these substances, that it creates a environment of connectivity. And then eventually, that goes away, and you go back to default mode, but the default mode now is not as rigid, is more enriched. And, to keep that going, it’s integration.

Having a good environment to come back to. You’re not getting re-traumatized And why do we know this? Is because psychedelics are also famously used for torture. And so you can expose people to terrible things when they’re in the suggestive state, and those [00:19:00] things can get patterned in.

This is the old saying, “Neurons that fire together, wire together.” So now you’ve created a new association. “Okay, this loved one that I remember” but what if then during your psychedelic experience I’m so grateful that I had that part of my life, and I love them so much, and it makes me feel this warmth in my whole body now, about how warm they were to me. and, all the concepts of afterlife you might have or, how they’re with you in a way that’s really affirming.

And now your association is with that, and that’s because you rewired your circuit around that stimulus. So that’s a little bit of how that neurobiology might be working .

Integration Practices

April Pride, host: And what are some ideas after you have the experience to continue with integration so that you can reinforce that rewiring

when it comes to

grief?

Dr. Sunil Aggarwal : There’s so many different realms of integration. There’s so many ways that people do this. a lot of people do integration groups. If you did this experience with other people, [00:20:00] to meet with those people again, and to have certain cues, that the music that you heard that day or the environment that you were in, those kinds of, salience cues will help you later on to revivify that.

Talking to people that, are integration coaches or therapists, people that knew you before and after or that are helping you support you through this process. those are all the sort of healthy ways to integrate. And you can do integration at your personal level, in relationships, and you can do it with your whole community.

April Pride, host: The default mode network Sunil just described is easier to picture than it sounds. Think of it as the brain’s autopilot, the background hum that runs your sense of self, your inner narrator, the story you keep telling yourself about who you are and what happened to you. It’s active when you’re daydreaming, ruminating, replaying an argument in your head.

Psilocybin quiets that autopilot , which is why people describe the experience as ego dissolution. The narrator goes quiet for a while. That’s exactly when [00:21:00] new connections between brain regions can form, ones that don’t usually talk to each other.

That’s the biological argument for why a single guided experience can shift a story you’ve been telling yourself about a loss for years

You might not have an answer for this, but it came up in my research.

an author named Yi-Yun Lee, she lost both of her sons to suicide. And she said the objects are the hardest thing for her. She can’t go into their rooms. She had to move her son’s stuff out of his dorm room. She’s “What do I do with this stuff that was his?” And so part of her integration was thinking through what is here that could be useful to somebody else It’s really powerful

You would want to have people with you as I think you’re moving through that experience and with those objects. so I think that the way that you can integrate this loss into your future, it’s [00:22:00] complicated, and it looks different for everybody.

But I had not thought of everything that person who is now gone has left behind.

I think of that in terms of cleaning out my grandmother’s house, but, with youth, it’s very different,

Hospice Bereavement Resource

Dr. Sunil Aggarwal : There’s a practice that’s, grown up around the country and the world where people are helping people with death, both those who are going through end of life, and then their families or people that leave behind, Also hospices if we’re talking about grief related to death, there’s lots of grief, but I wanna make sure everybody knows that every hospice is required to have 12 months of bereavement support for, any family who has lost a loved one.

and it’s not just open to people who were enrolled in the hospice. So you can call any hospice agency anywhere you are if you’re dealing with, and you want some help with grief counseling. And they both have one-on-one, and they also have groups. Don’t hesitate to do that.

They’re required by law to offer that. We have these little amazing niche here with hospice, so I wanna make sure everyone knows about [00:23:00] that.

There are bonfire traditions as well to let go of things.

April Pride, host: You’re right. That is a ritual that is very healing for a lot of people.

Before we close, I want to underline the one thing Sunil said that’s easiest to miss because he said it so plainly. Every hospice in this country is legally required to provide 12 months of bereavement support after a death, and it’s open to anyone in that family, not just people who were formerly enrolled as patients.

You do not need a hospice relationship to call and ask for it. You do not need to be actively dying or have a dying loved one right now. If cost or access to a psychedelic-assisted retreat is out of reach, and for most people it is, this is a real no-cost, legally mandated resource sitting mostly unused.

Call your local hospice agency. Ask for bereavement services.

Key Takeaways and Wrap

April Pride, host: Sunil keeps circling back to one distinction, [00:24:00] containment versus integration. Containment is what most of us default to. Put the loss in a box, keep it functioning, call it managed. Integration is slower and less tidy, and based on everything he described tonight, it’s also the only version that actually changes your relationship to the person or the thing you lost.

Not less pain, a different relationship to the pain. I wanna be direct about something. Nothing in this conversation is a replacement for grief counseling, a therapist, or your hospice’s bereavement program if you have access to one. Psychedelics didn’t invent integration. They can accelerate access to it for some people in the right setting with the right support around them.

That’s a meaningfully smaller claim than a cure, and it’s the honest one. If tonight raised something for you around your own grief or a loss you haven’t looked at directly in a while, that’s worth bringing to a therapist or grief counselor, not sitting with [00:25:00] alone.

You can find Dr. Aggarwal’s work and the AIMS Institute linked in the show notes. And if you had a question tonight we didn’t get to on the recording, the full audience Q&A from the Salon is its own episode. It’s going live next week.

And as you all know, the audience Q&A is my favorite part of every Salon. And speaking of Psychedelic Salon, it begins again October 8th with the history of LSD in Seattle, which is a really great story from start to finish. I hope you can join me live or live stream.

And remember, we have another Salon on November 12th, end-of-life care and how psychedelics is helping people with end-of-life care, end-of-life grief. This is April. Thanks for joining me. Until next time, take care.

[00:26:00]

 Dr. Sunil Aggarwal was interviewed on stage at Seattle Town Hall by April Pride. See video and transcript below.

Latest Blog Posts

Watch now: Psychedelics and Grief: When Containment Stops Working 

Watch now: Psychedelics and Grief: When Containment Stops Working 

Supporting women in the wild with science and wisdom about psychedelics. 134. Psychedelics and Grief: When Containment Stops Working Dr. Sunil Aggarwal joins April Pride to talk psilocybin, grief, and the difference between containing a loss and integrating it. April Pride Sep 29 Recently, it occurred to me that my relationship with trust needed tending. When I told a friend, she asked, “Why don’t you trust yourself?” I’ve been sitting with that question because it tracks and it confuses me at the same time. I’ve walked into divorce, entrepreneurship, and work in the Schedule I-adjacent world. Not the choices of ...

Read More
Breakthrough Therapeutics in Complex Illness

Breakthrough Therapeutics in Complex Illness

How Academy Members Are Integrating Psychedelics to Ease Distress Dr. Sunil Aggarwal is quoted in the feature story in the 2026 Fall Quarterly Newsletter from the American Academy of Hospice and Palliative Medicine. For patients facing serious illness, some of the deepest suffering cannot be measured on a numerical scale.  Some patients experience anxiety that does not respond to conventional treatment, as well as a deep sense of demoralization, isolation, and loss of meaning. Palliative and hospice care have long recognized treatment of this existential distress as central to whole-person care. Now, an emerging field of research is asking whether ...

Read More
Psychedelic science update & harm reduction training for naturopathic physicians

Psychedelic science update & harm reduction training for naturopathic physicians

8 CONTINUING EDUCATION (CE) HOURS FEBRUARY 1–4, 2027OPIHIHALE ETHNOBOTANICAL PRESERVEBig Island, Hawai‘i $2,850 INCLUDES Three nights lodging | All mealsGround transportation to and from Kona AirportCourse materials | Guided ethnobotanical tour AIMS Institute in collaboration with Opihihale Ethnobotanical Preserve WHY THIS COURSE? As interest in psychedelic therapies continues to grow, naturopathic physicians are increasingly asked about their safety, effectiveness, legal status, and appropriate clinical use. This immersive continuing education program provides an evidence-based review of current psychedelic science together with practical harm reduction strategies for clinicians whose patients are considering or using psychedelic medicines. Presented by the AIMS Institute in ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us